Skip to main content
WeightCited

Prebiotics/Inulin ： Obesity

C

Prebiotic fiber promotes SCFA production that enhances GLP-1/PYY secretion, strengthens gut barrier (reducing metabolic endotoxemia), and favorably shifts microbiome composition. Emerging evidence supports the gut-brain-adipose axis mediation of weight outcomes.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dprebiotics\u002Dinulin\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
結論

            
            
Prebiotic fiber promotes SCFA production that enhances GLP-1/PYY secretion, strengthens gut barrier (reducing metabolic endotoxemia), and favorably shifts microbiome composition. Emerging evidence supports the gut-brain-adipose axis mediation of weight outcomes.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
15

        
研究数

    

    

        
800

        
参加者数

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
グレード

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
一般的な使用量

                

                    
                    

                        
general:

                        
5-10 g/day

                    

                    
                    

                        
starting:

                        
3-5 g/day and increase gradually over 1-2 weeks

                    

                    
                    

                        
satietyeffects:

                        
10-16 g/day oligofructose/inulin

                    

                    
                

                
                

                    上限量： 20 g/day (GI tolerance limit — bloating, gas, cramping above this)
                

                
            

            

            

            
            

                推奨摂取タイミング： With meals; gradual dose escalation to minimize GI discomfort
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
報告されている副作用

                    
    
                        
                        
  • 
                            ⚠
                            Bloating
                        
    • 
                        
                        
  • 
                            ⚠
                            Gas
                        
    • 
                        
                        
  • 
                            ⚠
                            Cramping
                        
    • 
                        
                        
  • 
                            ⚠
                            Diarrhea (at high doses)
                        
    • 
                        
                    

                

                

                
                

                    
既知の相互作用

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may affect blood sugar through improved insulin sensitivity)
                        
    • 
                        
                    

                

                

                
                

                    

                        耐容上限摂取量： 20 g/day (GI tolerance limit — bloating, gas, cramping above this)
                    

                

                
            

            

                サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Prebiotics/Inulin help with Obesity?
            
        
        

            Based on 15 studies with 800 participants, there is limited but promising evidence that Prebiotics/Inulin may support Obesity management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Prebiotics/Inulin should I take for Obesity?
            
        
        

            Studies have used various dosages. A commonly studied range is 5-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Prebiotics/Inulin?
            
        
        

            Reported side effects may include Bloating, Gas, Cramping, Diarrhea (at high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Prebiotics/Inulin and Obesity?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
Prebiotics/Inulin 他の症状・状態について

                    

                        
                        
                            Appetite Control
                            B

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。